|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
Rotterdam, Rotterdam 3029, NL
|
|
Allero Therapeutics is a Dutch, venture-backed, biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long-lasting antigen-specific tolerance.
Our proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with novel oral patch mediated targeted delivery of specific antigens to the oral mucosa immune privilege.
|
Allero Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Allero Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Allero Therapeutics customer service number in your country click here to find.
Emil Pot is the CEO of Allero Therapeutics.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.